arrow_back Back Filing freshness 10-Q Q2 FY2026 SEC EDGAR

Greenland Mines Ltd

GRML
$12.89 ▼ -1.21 (-8.58%) at close
Healthcare ·Biological Products, (No Diagnostic Substances) ·USBiological Products, (No Diagnostic Substances)
22 Visible periods
20 Metrics
Peer-ranked Benchmarks
Price Chart
16
Health
Poor
Bearish
auto_awesome

Analytical Summary

Greenland Mines Ltd faces fundamental challenges with weakness in Return on Common Equity (%). The fundamentals warrant careful consideration of downside risks.

Market Cap $1.6B
Dividend Yield
Revenue Growth
Op. Margin
ROIC -7.5%
FCF / Share $-0.05
Trailing P/E
Price / Book 35.4x
FCF Yield
Debt / Equity
info Valuation on last close. End-of-day price, Sep 23, 2026.

22-Year Financial Trajectory

Quarterly
Metric Value Trend Year over Year Percentile
Net Income Profit after all expenses
$-13.86M
↓ -520.3%
FCF / Share Free cash flow per share
$-0.05
↓ -2.1%
trending_up

Bullish Indicators

  • No bullish signals detected.
warning

Bearish Risks

  • Return on Common Equity (%)Return on Common Equity (%) is in the bottom quartile

Health Breakdown

Returns
8
Financial Health
14
Cash Quality
42

Dividend History

Dividend / share · sourced from SEC filings
$16.50 Latest / share

bar_chart Data from SEC EDGAR XBRL filings

Synced yesterday 5 years · 22 quarters